Alliance A082002 -a randomized phase II/III trial of modern immunotherapy-based systemic therapy with or without SBRT for PD-L1-negative, advanced non-small cell lung cancer

Authors:

Abstract
No abstract available
Funding Information
  • National Institutes of Health (U10CA180820, U10CA180821, U10CA180868, U10CA180882, U10CA180888, UG1CA232760, UG1CA233180, UG1CA233191, UG1CA233253, UG1CA233277)
  • Foundation for the National Institutes of Health
  • National Cancer Institute

This publication has 13 references indexed in Scilit: